1. India Stocks

  2. •

    Financial Services

  3. •

    Financial - Conglomerates
Amerise Biosciences Ltd.

Amerise Biosciences Ltd.

AMERISE.BO
Amerise Biosciences Ltd.IN flagBombay Stock Exchange
0.81
INR
- -
- -
53.52MMarket Cap
Amerise Biosciences Ltd.
AMERISE.BO
(Bombay Stock Exchange)

Recent

price

0.81

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
0.18
- -
- -
1.36
- -
- -
- -
- -
- -
Revenue per Share
- -
- -
- -
- -
-0.01
- -
-0.14
- -
- -
-0.02
-0.05
0.08
-0.02
-0.02
- -
- -
- -
Basic EPS, GAAP
0.77
0.16
-0.72
0.41
0.04
0.16
-0.54
-0.01
-0.27
0.74
-0.06
0.01
-0.02
-0.03
0.46
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
1
1
0.99
0.99
0.98
0.98
0.83
0.83
0.83
0.81
0.76
0.84
0.82
0.8
0.8
- -
1.02
Book Value per Share
1.01
1.01
1
1
0.99
0.99
0.85
0.84
0.84
0.82
0.77
0.85
0.84
0.81
0.81
- -
0.83
Tangible Book Value per Share
66
66
66
66
66
66
66
66
66
66
66
66
66
66
66
- -
65
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
12
- -
- -
90
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
0.35
- -
- -
-0.22
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
-9
- -
- -
-1
-3
5
-1
-1
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
25
21.84
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
0.35
- -
- -
6.1
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
48
20
37
1
27
27
45
-6
-5
- -
- -
- -
-31
-14
-14
Working Capital
13
26
27
6
- -
- -
- -
- -
- -
- -
- -
1
1
- -
- -
- -
- -
LT Debt
67
67
66
66
66
65
56
56
56
54
51
56
55
54
54
54
54
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
0.07
- -
- -
-0.37
- -
- -
0.1
0.3
-1.7
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
0.07
- -
- -
10.31
- -
- -
0.11
0.27
0.35
Return on Capital (%)
-0.36
-0.46
-0.48
-0.4
-0.73
-0.44
-15.71
-0.39
0.07
-2.75
-6.51
10.4
-2.16
-2.72
0.11
0.27
0.35
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
66
- -
66
Market Capitalization
41
38
38

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
- -
- -
6
Cash, Cash Equivalents & STI
- -
- -
6
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
31
- -
20
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-1.71%
1.29%
0.3%
Free Cash Flow
48.46%
-489.93%
-134.41%
Net Income, GAAP
-85.96%
-56.62%
182.46%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.01
-0.01
-0.01
- -
-0.02
2025
-0.01
-0.01
- -
0.02
- -
2026
- -
-0.01
- -
0.01
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Fineqia International Inc. (FNQ.CN)
HCM IV Acquisition Corp. Class A Ordinary Share (HACQ)
Aksys Ltd. (AKSY)
Agriculture & Natural Solutions (ANSC)
KDventures AB (KDEV.ST)
RRE Ventures Acquisition Corp. (RREV)
Business
Amerise Biosciences Ltd (AMERISE.BO) operates as a biotechnology company focused on research and development in healthcare solutions; however, it currently maintains no significant operations. The company offers innovative biopharmaceutical products targeting various medical conditions, with an emphasis on enhancing patient outcomes through sustainable and quality-driven advancements in the Indian biotech sector. Previously engaged in commodity trading, plastic products, decorative laminates, boards, construction equipment, and agricultural equipment manufacturing, it now prioritizes biotechnology amid low revenue generation of approximately 0.32 crore rupees and inconsistent profitability. Amerise Biosciences serves consumers and healthcare providers primarily in India, with potential expansion in digital services and R&D initiatives. Incorporated in 1984 and headquartered at 24 Laxmi Chambers, Navjeevan Press Road, Ahmedabad, Gujarat, India, it changed its name from Amradeep Industries Limited in December 2021 to reflect its pivot toward biosciences. Recent developments include reporting a standalone net loss of 0.04 crore rupees for the quarter ended September 2025, alongside board meetings in 2025 to approve unaudited financial results, but no major acquisitions, partnerships, funding rounds, or new product launches have been announced in the last 1-2 years.